Asthma (1 of 26)

Asthma (1 of 26)

Asthma (1 of 26) 1 Patient presents w/ signs & symptoms suggestive of asthma 2 3 DIAGNOSIS No ALTERNATIVE Is asthma DIAGNOSIS confi rmed? Yes ASSESS THE LEVEL OF CONTROL OF ASTHMA FOR THE PAST 4 WEEKS Controlled Partly Controlled Uncontrolled (All of the (Presence of 1-2 of these) (Presence of 3-4 of these) following) Children Adolescents Children Adolescents & ≤5 years old & Children ≤5 years old Children 6-11 years old 6-11 years old Frequency of daytime None >Few >2x/week >Few >2x/week symptoms minutes, minutes, >once a week >once a week Limitation of activities None Any Any Any Any Nocturnal waking up or None Any Any Any Any coughing due to asthma Need for reliever None >once/week >2x/week >once/week >2x/week medication* *Reliever medications taken prior to exercise excluded. Modified from: Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention: Updated 2020. TREATMENT A Patient/guardian/caregiver education B Initial treatment of asthma C Management plans for long-term asthma control D Primary prevention E © Periodic assessmentMIMS & monitoring Not all products are available or approved for above use in all countries. Specifi c prescribing information may be found in the latest MIMS. B13 © MIMS Pediatrics 2020 Asthma (2 of 26) 1 ASTHMA • A heterogeneous disease w/ chronic infl ammatory disorder of the airways • e most common chronic disease in pediatric age groups that causes signifi cant morbidity • Characterized by history of respiratory symptoms eg wheeze, shortness of breath, chest tightness & cough ASTHMA that vary over time & in intensity, together w/ variable expiratory airfl ow limitation • Symptoms occur w/ exercise, laughing or crying in the absence of an apparent respiratory infection Symptoms (Recurrent Episodes) • Wheezing • Breathlessness • Heavy breathing • Chest tightness • Reduced activity • Cough that is recurrent or persistent non-productive that may be worse at night 2 DIAGNOSIS History • Identify the symptoms likely to be due to asthma • Determine symptom pattern for the past 3-4 months - Focus on symptoms that occurred in the past 2 weeks • History of variability is essential in the diagnosis of asthma - Variability refers to improvement or worsening of symptoms & lung function occurring over a period of time (eg day to day, month to month or seasonally) Key Indicators for Considering a Diagnosis of Asthma • Episodes of wheezing occurring more than once a month or symptoms occur >3 episodes/year - Wheezing occurring during sleep, activity, laughing, or crying, & with increasing recurrence is likely due to asthma • Activity-induced cough, usually accompanied by wheeze or heavy breathing - Cough should be non-productive, & recurrent or persistent • Nighttime cough or wheeze in the absence of viral infection • Heavy breathing, shortness of breath, or diffi cult breathing during exercise or activity, that is noticeably recurrent increases the likelihood of asthma • Persistence of asthma symptoms beyond age 3 years • Symptoms triggered or exacerbated by animal fur, aerosol, temperature changes, dust mites, drugs, etc • Symptoms (eg cough, wheeze, heavy breathing) lasting longer than 10 days in the presence of an upper respi- ratory tract infection (URTI) • Symptoms improve w/ asthma medication • Presence of patient history or family history of allergic disease (eg atopic dermatitis, allergic rhinitis) Physical Exam • Perform a thorough exam w/ focus on observation of forced expiration & nasal inspection • Hyperexpansion of the thorax • Wheezing during normal breathing or prolonged forced exhalation • Increased nasal secretion, mucosal swelling or nasal polyps • Signs of allergic skin condition • Occasionally, wheezing may not be seen in severe asthma attacks due to markedly reduced airfl ow & ventilation - Other signs may be present (eg cyanosis, drowsiness, tachycardia, diffi culty speaking) Pulmonary Function Testing Spirometry • Preferred diagnostic method - Measures airfl ow limitation & determines reversibility - All measurements should be done before & after administration of inhaled short-acting bronchodilator • Generally valuable in children ≥5 years of age - Some children cannot correctly execute the required maneuvers until age 7 years • Forced vital capacity (FVC) is a measure of the maximal volume of air exhaled from the point of maximal inhalation • © MIMS Volume of air exhaled during the 1st second of this maneuver is called forced expiratory volume in 1 second (FEV1) - FEV1 indicates risk for exacerbations • FEV1/FVC appears to be a more sensitive measure of severity of impairment • Increase in FEV1 ≥12% after administration of a bronchodilator indicates reversible airfl ow limitation B14 © MIMS Pediatrics 2020 Asthma (3 of 26) 2 DIAGNOSIS (CONT’D) Pulmonary Function Testing (Cont'd) Peak Expiratory Flow (PEF) Measurements • Important in diagnosis & monitoring of asthma ASTHMA Bronchodilator Response • Determines reversibility of airfl ow limitation in response to treatment Fractional Concentration of Exhaled Nitric Oxide (FENO) Measurement • Associated w/ increases in eosinophilic levels • An increase in FENO >4 weeks after an URTI in preschool children w/ recurrent symptoms may help in the diagnosis & in predicting intranasal corticosteroid use by school-age • Further studies are needed to prove the use of FENO measurement as a guide for adjusting asthma treatment Other Tests • ere are several lung function tests that do not rely on patient’s cooperation or the ability to perform the required maneuvers - May be valuable in children 2-5 years of age - ese are not evaluated as diagnostic tests for asthma - Commonly used in research studies & specialist centers - Eg impulse oscillometry, specifi c airway resistance, measurements of residual volume • Chest radiography may be used to rule out other pathologies & structural abnormalities Allergy Tests • Presence of food-specifi c IgE &/or atopic dermatitis increases the risk of sensitization to inhaled allergens & may be predictive of developing asthma In vivo Test • Skin prick test In vitro Test • IgE panel test/radioallergosorbent test (RAST) - May be done if in vivo test cannot be performed (eg cases of severe dermatitis) - May be performed if current antihistamine therapy cannot be discontinued, or if there is a known possibility of a life-threatening reaction to food or inhalant Asthma Diagnosis in Children ≤5 Years • Objective measurements of lung function may be diffi cult in this age group • Atopy is a major risk factor for subsequent development of asthma in this age group & it also predicts severity once asthma develops • To help establish a diagnosis of asthma, a diagnostic trial of asthma medications, in addition to a thorough medical history & physical exam, may be useful • Consider asthma if >3 episodes of reversible bronchial obstruction have been noted within the last 6 months - Patients may have virus-induced asthma which is common in this age group 3 ALTERNATIVE DIAGNOSIS Upper Airway Diseases • Allergic rhinitis & chronic rhinosinusitis Large-airway Obstruction • Foreign body obstruction of trachea or bronchus • Vocal cord dysfunction • Vascular rings or laryngeal webs • Enlarged lymph nodes or tumor • Laryngotracheomalacia, tracheal stenosis or bronchostenosis Small-airway Obstruction • Bronchiolitis (viral or obliterative) • Cystic fi brosis • Bronchopulmonary dysplasia • Congenital© heart disease MIMS Other Causes • Recurrent viral lower respiratory tract infection • Tuberculosis • Immune defi ciency • Aspiration due to dysfunction in swallowing mechanism or gastroesophageal refl ux B15 © MIMS Pediatrics 2020 Asthma (4 of 26) A PATIENT/GUARDIAN/CAREGIVER EDUCATION • Includes skills training, symptom monitoring, & a written personal asthma action plan • Aims to actively involve the children, their families & caregivers in managing asthma • Education should be provided over several visits ASTHMA - Studies have shown that asthma control is improved w/ the use of written asthma management plan together w/ careful verbal explanation of the treatment regimen • Develop patient/doctor partnership - Objective is to give patients the ability to control their asthma w/ guidance from health care professionals • e patient, parents & caregivers should be able to apply the following objectives - Avoid triggers & aggravating factors - Take medications accurately & appropriately - Understand the diff erence between “controller” & “reliever” medications - Train about correct inhalation technique - Monitor asthma control status - Recognize signs of worsening asthma & take appropriate action - Seek medical help when necessary Written Asthma Action Plan • May help patients & patient's parents/guardian/caregiver recognize & respond appropriately to an asthma attack • Should include specifi c, individualized instructions about medications & medical care access • Changes to medications may include the following: - Increasing as-needed inhaled low-dose corticosteroid-Formoterol doses - e use of an inhaler containing rapid-onset long-acting beta2-agonist w/ low-dose corticosteroid - Other inhaled corticosteroids & inhaled corticosteroid-long-acting beta2-agonist maintenance controlled regimens - A short-course oral corticosteroids for patients unresponsive to increased doses of reliever & controller medications, rapid deterioration, PEF or FEV1 <60% of personal best, or a history of sudden severe exacerbations B INITIAL TREATMENT OF ASTHMA • After diagnosis of asthma is made, it is recommended to start corticosteroid (inhaled,

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    26 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us